BR0108146A - Processo e intermediários para o preparo de inibidores da protease retroviral - Google Patents
Processo e intermediários para o preparo de inibidores da protease retroviralInfo
- Publication number
- BR0108146A BR0108146A BR0108146-2A BR0108146A BR0108146A BR 0108146 A BR0108146 A BR 0108146A BR 0108146 A BR0108146 A BR 0108146A BR 0108146 A BR0108146 A BR 0108146A
- Authority
- BR
- Brazil
- Prior art keywords
- protease inhibitors
- intermediates
- preparation
- retroviral protease
- amino
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title abstract 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title abstract 2
- 230000001177 retroviral effect Effects 0.000 title abstract 2
- AMPWQTJNJASABL-UHFFFAOYSA-N 1,6-diphenylhexan-1-amine Chemical compound C=1C=CC=CC=1C(N)CCCCCC1=CC=CC=C1 AMPWQTJNJASABL-UHFFFAOYSA-N 0.000 abstract 1
- -1 2,6-dimethylphenoxyacetyl Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65191900A | 2000-08-31 | 2000-08-31 | |
| PCT/US2001/026898 WO2002018349A2 (en) | 2000-08-31 | 2001-08-29 | Process and intermediates for preparing retroviral protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0108146A true BR0108146A (pt) | 2004-01-06 |
Family
ID=24614772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0108146-2A BR0108146A (pt) | 2000-08-31 | 2001-08-29 | Processo e intermediários para o preparo de inibidores da protease retroviral |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1313712B1 (ko) |
| JP (1) | JP5021141B2 (ko) |
| KR (1) | KR100806533B1 (ko) |
| CN (1) | CN1264823C (ko) |
| AT (1) | ATE361913T1 (ko) |
| AU (1) | AU2001286889A1 (ko) |
| BR (1) | BR0108146A (ko) |
| CA (2) | CA2416955C (ko) |
| CY (1) | CY1106738T1 (ko) |
| DE (1) | DE60128367T2 (ko) |
| DK (1) | DK1313712T3 (ko) |
| ES (1) | ES2284684T3 (ko) |
| HK (1) | HK1057040A1 (ko) |
| IL (1) | IL153436A0 (ko) |
| MX (1) | MXPA03001751A (ko) |
| PT (1) | PT1313712E (ko) |
| WO (1) | WO2002018349A2 (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2378669T3 (es) * | 2003-12-11 | 2012-04-16 | Abbott Laboratories | Compuestos inhibidores de proteasa de VIH |
| CN100358521C (zh) * | 2004-12-28 | 2008-01-02 | 哈尔滨欧替药业股份有限公司 | 一种双唑泰栓剂及其制备工艺 |
| CN103910634B (zh) * | 2012-12-29 | 2018-04-27 | 广东东阳光药业有限公司 | 西格列汀中间体的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5914332A (en) * | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
-
2001
- 2001-08-29 CN CNB018148646A patent/CN1264823C/zh not_active Expired - Lifetime
- 2001-08-29 MX MXPA03001751A patent/MXPA03001751A/es active IP Right Grant
- 2001-08-29 ES ES01966367T patent/ES2284684T3/es not_active Expired - Lifetime
- 2001-08-29 DE DE60128367T patent/DE60128367T2/de not_active Expired - Lifetime
- 2001-08-29 CA CA2416955A patent/CA2416955C/en not_active Expired - Lifetime
- 2001-08-29 WO PCT/US2001/026898 patent/WO2002018349A2/en active IP Right Grant
- 2001-08-29 EP EP01966367A patent/EP1313712B1/en not_active Expired - Lifetime
- 2001-08-29 JP JP2002523467A patent/JP5021141B2/ja not_active Expired - Lifetime
- 2001-08-29 KR KR1020037002869A patent/KR100806533B1/ko active IP Right Grant
- 2001-08-29 DK DK01966367T patent/DK1313712T3/da active
- 2001-08-29 AT AT01966367T patent/ATE361913T1/de active
- 2001-08-29 CA CA2731273A patent/CA2731273C/en not_active Expired - Lifetime
- 2001-08-29 IL IL15343601A patent/IL153436A0/xx active IP Right Grant
- 2001-08-29 AU AU2001286889A patent/AU2001286889A1/en not_active Abandoned
- 2001-08-29 BR BR0108146-2A patent/BR0108146A/pt not_active Application Discontinuation
- 2001-08-29 PT PT01966367T patent/PT1313712E/pt unknown
-
2003
- 2003-10-17 HK HK03107574A patent/HK1057040A1/xx not_active IP Right Cessation
-
2007
- 2007-07-16 CY CY20071100952T patent/CY1106738T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2284684T3 (es) | 2007-11-16 |
| DE60128367T2 (de) | 2008-01-10 |
| CA2731273A1 (en) | 2002-03-07 |
| CY1106738T1 (el) | 2012-05-23 |
| AU2001286889A1 (en) | 2002-03-13 |
| ATE361913T1 (de) | 2007-06-15 |
| MXPA03001751A (es) | 2003-09-10 |
| KR20030061787A (ko) | 2003-07-22 |
| CN1264823C (zh) | 2006-07-19 |
| WO2002018349A2 (en) | 2002-03-07 |
| KR100806533B1 (ko) | 2008-02-25 |
| WO2002018349A3 (en) | 2002-05-10 |
| EP1313712A2 (en) | 2003-05-28 |
| JP5021141B2 (ja) | 2012-09-05 |
| DE60128367D1 (de) | 2007-06-21 |
| CA2731273C (en) | 2013-10-15 |
| EP1313712B1 (en) | 2007-05-09 |
| CA2416955A1 (en) | 2002-03-07 |
| PT1313712E (pt) | 2007-07-25 |
| CA2416955C (en) | 2011-04-26 |
| HK1057040A1 (en) | 2004-03-12 |
| CN1449388A (zh) | 2003-10-15 |
| DK1313712T3 (da) | 2007-09-10 |
| JP2004507528A (ja) | 2004-03-11 |
| IL153436A0 (en) | 2003-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0209984A (pt) | Processo para a preparação de prostaglandinas e seus análogos | |
| BR9909844A (pt) | Processo para sintetizar um composto, e, composto. | |
| NL300283I1 (nl) | Alfa- en bèta-aminozuur-hydroxyethylamino-sulfonamiden die toepasbaar zijn als retrovirale-prothease-remmers. | |
| BR9812837A (pt) | Processo para fazer um composto, e, composto | |
| BR0111319A (pt) | Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário | |
| BR0109836A (pt) | Processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis | |
| TW200517374A (en) | Cyclohexanecarboxylic acids | |
| BR9815469A (pt) | Inibidores de protease | |
| BR9909739A (pt) | Benzotiadiazóis e derivados | |
| BR0101230A (pt) | Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina | |
| BR0211691A (pt) | Processo para a prepara de tolterodina | |
| BR9708233A (pt) | Processo para sìntese de um composto e composto. | |
| BR0212772A (pt) | Processo para a preparação de repaglinida | |
| BR0316400A (pt) | agentes branqueadores fluorescentes anfotéricos | |
| BR9807988A (pt) | Processo para a preparação de um composto, e, composto. | |
| BR9808923A (pt) | Composto, e, processo para fazer o mesmo | |
| BR0212390A (pt) | Processo para a preparação de cilastatina | |
| BR0002505A (pt) | Derivados de 4-arilpiperidina para o tratamento de prurido | |
| BR0108146A (pt) | Processo e intermediários para o preparo de inibidores da protease retroviral | |
| BR9814495A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo | |
| BR0009453A (pt) | Processo para a preparação de um composto | |
| BR0209842A (pt) | Processo para a preparação de imipenem | |
| BR9807785A (pt) | Processo para a preparação do composto, e, composto | |
| BR0015022A (pt) | Processo para a preparação de cloridrato de n-(4,5-bismetanossulfonil-2-metilbenzoil) guanidina | |
| BR0116721A (pt) | Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. C07D 239/00, A61P 31/00 Ipc: C07D 239/00 (2011.01), A61P 31/00 (2011.01) |
|
| B25A | Requested transfer of rights approved |
Owner name: ABBVIE INC. (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |